| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6221392 | MEDA PHARMS | Rapidly dissolving robust dosage form |
Apr, 2018
(6 years ago) | |
| US6024981 | MEDA PHARMS | Rapidly dissolving robust dosage form |
Apr, 2018
(6 years ago) | |
Reglan Odt is owned by Meda Pharms.
Reglan Odt contains Metoclopramide Hydrochloride.
Reglan Odt has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Reglan Odt are:
- US6221392
- US6024981
Reglan Odt was authorised for market use on 10 June, 2005.
Reglan Odt is available in tablet, orally disintegrating;oral dosage forms.
The generics of Reglan Odt are possible to be released after 09 April, 2018.
Drugs and Companies using METOCLOPRAMIDE HYDROCHLORIDE ingredient
Market Authorisation Date: 10 June, 2005
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
More Information on Dosage
REGLAN ODT family patents
